Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low risk of OHSS with follitropin delta use in women with different polycystic ovary syndrome phenotypes: a retrospective case series.

Journal of ovarian research - 12 Feb 2021

Yacoub Stephanie, Cadesky Kenneth, Casper Robert F

Abstract excerpt

BACKGROUND: To explore the efficacy of follitropin delta in ovarian stimulation of patients with the Rotterdam ESHRE/ASRM 2003 phenotypes of polycystic ovarian syndrome (PCOS) using a retrospective case series with an electronic file search in a reproductive medicine clinic. CASE PRESENTATION: Seventy-four patients with PCOS undergoing ovarian stimulation according to the individualized dosing algorithm of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aromatase Inhibitors
Share to Chorionic Gonadotropin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dopamine Agonists

Share to Gonadotropin-Releasing Hormone

Share to Hyperandrogenism

Share to Ovulation Induction

Share to Pregnancy Rate

Share to Sperm Injections, Intracytoplasmic

Source

Open in PubMed Open full text

Identifiers

PMID: 33579321
DOI: 10.1186/s13048-021-00773-5
PMCID: PMC7881448

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low risk of OHSS with follitropin delta use in women with different polycystic ovary syndrome phenotypes: a retrospective case series.PMID 33579321Read ↗

Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trialSemantic proximity Read ↗

Phenotype-specific efficacy of letrozole versus clomiphene citrate in polycystic ovary syndrome: a prospective cohort study.Semantic proximity Read ↗

Cumulative live birth rate after ovarian stimulation with freeze-all in women with polycystic ovaries: does the polycystic ovary syndrome phenotype have an impact?Semantic proximity Read ↗

Ovarian stimulation in assisted reproductive technology cycles for varied patient profiles: An Indian perspectiveSemantic proximity Read ↗

Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypesSemantic proximity Read ↗

Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): what's the difference?Semantic proximity Read ↗

Aromatase inhibitors for subfertile women with polycystic ovary syndromeSemantic proximity Read ↗

The Association of Exaggerated Folliculer Responses to Clomiphene Citrate With Estrogen and Follicle-stimulating Hormone Receptor Polymorphisms in Women With Polycystic Ovary SyndromeSemantic proximity Read ↗

Ovarian stimulation protocols: impact on oocyte and endometrial quality and functionSemantic proximity Read ↗

The HERA (Hyper-response Risk Assessment) Delphi consensus definition of hyper-responders for in-vitro fertilizationSemantic proximity Read ↗

Pharmacogenetics of controlled ovarian hyperstimulation.Semantic proximity Read ↗

The HERA (Hyper-response Risk Assessment) Delphi consensus for the management of hyper-responders in in vitro fertilizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.